Thrivent Financial For Lutherans lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 85.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,975 shares of the company’s stock after selling 69,320 shares during the quarter. Thrivent Financial For Lutherans’ holdings in Cardinal Health were worth $933,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in CAH. Bronfman E.L. Rothschild L.P. grew its position in Cardinal Health by 31.8% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after buying an additional 382 shares during the period. JFS Wealth Advisors LLC grew its position in Cardinal Health by 14.3% during the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after buying an additional 244 shares during the period. Dupont Capital Management Corp acquired a new stake in Cardinal Health during the second quarter valued at $164,000. First Personal Financial Services grew its position in Cardinal Health by 127.5% during the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after buying an additional 1,238 shares during the period. Finally, Alpha Windward LLC grew its position in Cardinal Health by 0.7% during the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after buying an additional 17 shares during the period. Institutional investors own 87.98% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/08/thrivent-financial-for-lutherans-has-933000-position-in-cardinal-health-inc-cah.html.

Cardinal Health, Inc. (NYSE:CAH) opened at 65.88 on Friday. The firm has a market cap of $20.85 billion, a PE ratio of 16.35 and a beta of 0.86. The firm’s 50-day moving average is $67.17 and its 200 day moving average is $73.43. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $84.88.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 earnings per share. Equities research analysts predict that Cardinal Health, Inc. will post $4.95 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.81%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s payout ratio is currently 45.79%.

Several research firms recently commented on CAH. UBS AG restated a “neutral” rating and set a $76.00 price target (down previously from $79.00) on shares of Cardinal Health in a research report on Thursday, August 3rd. Credit Suisse Group reiterated an “outperform” rating and issued a $87.00 target price (up previously from $81.00) on shares of Cardinal Health in a research report on Thursday, July 13th. BidaskClub lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a research report on Monday, August 7th. Finally, Cowen and Company reiterated a “market perform” rating and issued a $77.00 target price (down previously from $82.00) on shares of Cardinal Health in a research report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.81.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.